Stocks in play: CGI Inc.
Released strong first-quarter 2023 results. Revenue of $3.45 billion, up 11.6% year-over-year or 12.3% year-over-year in constant currency; Adjusted EBIT of $554.1 million, up 6.3% year-over-year, for a margin of 16.1%; Net earnings of $382.4 million, up 4.1% year-over-year, for a margin of 11.1%; Net earnings excluding specific items of $398.2 million, up 7.8% year-over-year, for a margin of 11.5%; Diluted EPS of $1.60, up 7.4% year-over-year. CGI Inc. shares T.GIB.A are trading up $5.83 at $119.87.
Read:
Addressing the USA’s 200 to 1 Security Protection Gap is a Serious Concern for Tech Companies
Latest Set of FDA Fast Track Designations Causing Optimism in Biotech Sector
Biotech Sector to Unveil New Data and Developments at 2022 SABCS in San Antonio
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer
New Biotech Sector Drug Combinations Target a Drop in Pancreatic Cancer Mortality Rates